Market Notice 16/25 – Updated information regarding the rights issue from PEPTONIC Medical AB

Referring to PEPTONIC Medical AB’s press release from January 21, 2025, the trading period and subscription period will be extended.    

Please see Market Notice 275/24 – Information regarding the rights issue from PEPTONIC Medical AB for the original Market Notice. 

The last day of trading in the company’s shares PMED including the right to receive unit rights was January 7, 2025. The first day excluding the right to obtain the rights was January 8, 2025. 

One (1) share entitles the owner to one (1) unit right. Fifty (50) unit rights entitle the owner to subscribe for one (1) new unit, at the price of SEK 0,23.  
One unit consists of fifty (50) new shares (50:50 á SEK 0,0046). (unchanged)    

The subscription period lasts from January 13, 2025, (unchanged) to February 24, 2025. (changed)    

Information about the unit right:   
Shortname: PMED UR (unchanged)    
ISIN-code: SE0023615786 (unchanged)    
Orderbook-ID: 377913 (unchanged)    
CFI: RSIXXR (unchanged)    
FISN: PEPTONICME/SUBS RTS NL PD (unchanged)    
First day of trading: January 13, 2025 (unchanged)    
Last day of trading: February 19, 2025 (changed) 
Market Segment: SPSE (unchanged)    
MIC Code: XSAT (unchanged)    
Tick size: 2  (unchanged)    

Information about the paid subscribed unit:    
Shortname: PMED BTU (unchanged)    
ISIN-code: SE0023615794 (unchanged)    
Orderbook-ID: 377914 (unchanged)    
CFI: MCMUXR (unchanged)    
FISN: PEPTONICME/UT 50 AK (unchanged)    
Trading period: January 13, 2025, until the registration of the issue at Bolagsverket. (unchanged)    
Market Segment: SPSE (unchanged)    
MIC Code:  XSAT (unchanged)    
Tick size: 2 (unchanged)    

Stockholm January 21, 2025 

Spotlight Stock Market 
08-511 68 000   
backoffice@spotlightstockmarket.com